Fluomizin vaginal tablets 10 mg blister 6 pcs.

The active substance is dequalinium chloride (one vaginal tablet contains 10 mg of dequalinium chloride).

Excipients: lactose monohydrate; microcrystalline cellulose; magnesium stearate.

• hypersensitivity to the active substance or to any of the excipients;
• ulcers of the epithelium of the vagina and the vaginal part of the cervix;
• Do not use in young girls who have not had their first menstruation and who have not reached puberty.

It is recommended to use one vaginal tablet daily for 6 days. The vaginal tablet should be inserted deep into the vagina in the evening before going to bed. It is best to do this while lying on your back with your legs slightly bent.

Treatment should be discontinued during menstruation and continued after menstruation has stopped.

Although the discharge and inflammation usually subside within 24-72 hours, treatment should be continued even if discomfort (itching, discharge, odor) is no longer present. Treatment lasting less than 6 days may result in relapse. The course of treatment is 6 days.

Pregnant women

“Fluomizine” can be used during pregnancy or breastfeeding.

This drug can be used during lactation if clinically necessary.

Children

Not recommended for use in children.

There have been no reports of overdose. However, exceeding the daily dose may lead to the formation of ulcers of the vaginal epithelium.

From the genitals and mammary glands: often (≥ 1/100 to <1/10) – vaginal discharge, vulvovaginal itching, burning sensation in the vulvovaginal area.

Infectious and parasitic diseases: often (≥ 1/100 to <1/10) – vaginal candidiasis.

Store in the original packaging at a temperature not exceeding 30 °C, out of the reach of children.

Shelf life – 3 years.